Aquazide is a brand of hydrochlorothiazide, a thiazide diuretic often called a water pill. It helps lower high blood pressure and reduces swelling (edema) caused by heart failure, liver disease, kidney disorders, or certain medications. By helping your kidneys excrete extra salt and water, Aquazide decreases fluid overload, eases symptoms such as ankle swelling, and reduces cardiovascular risk when used as part of a comprehensive plan. It is commonly combined with other antihypertensives and lifestyle changes. This guide explains uses, dosing, precautions, side effects, interactions, and U.S. prescription rules so you can discuss Aquazide confidently with your healthcare professional today.
Aquazide is a thiazide diuretic used primarily to treat high blood pressure (hypertension) and fluid retention (edema). By promoting sodium and water excretion in the distal tubules of the kidneys, it reduces circulating fluid volume. For people with hypertension, this helps lower blood pressure and, over time, reduces the risk of heart attack, stroke, and kidney disease when combined with broader cardiovascular risk management.
In edema, Aquazide helps relieve swelling associated with heart failure, chronic kidney disease, nephrotic syndrome, and certain liver conditions. It may also be used to counteract medication-related fluid retention, such as from some corticosteroids. Clinicians often combine Aquazide with other antihypertensives (ACE inhibitors, ARBs, beta blockers, calcium channel blockers) to achieve target blood pressure while leveraging complementary mechanisms.
Because thiazides can lower urinary calcium excretion, hydrochlorothiazide has additional niche uses, such as prevention of recurrent calcium-containing kidney stones in select patients. All off-label uses should be directed by a clinician who can monitor labs and outcomes.
Dosing is individualized. For hypertension, many adults start at 12.5–25 mg once daily in the morning. If needed, clinicians may titrate to 25–50 mg daily, balancing blood pressure control with the increased risk of metabolic side effects at higher doses. For edema, typical doses range from 25–100 mg daily, given once daily or in divided doses; some patients benefit from intermittent dosing (for example, every other day) to minimize electrolyte shifts. Your prescriber will tailor the regimen to your goals and response.
Take Aquazide at the same time each day, preferably in the morning to reduce nighttime urination. Swallow tablets with water, with or without food. Consistent dietary sodium intake helps your clinician interpret your response; large swings in salt intake can blunt or exaggerate the diuretic effect.
Special populations: Older adults may need lower starting doses to avoid excessive diuresis and electrolyte disturbances. In chronic kidney disease, thiazides are less effective as monotherapy when estimated GFR falls below ~30 mL/min/1.73 m²; your clinician may adjust therapy or combine with a loop diuretic in select cases. Pediatric dosing, when indicated, is weight-based and requires pediatric specialist guidance. Never change your dose without medical advice.
Electrolytes and volume status: Thiazides can cause or worsen hyponatremia, hypokalemia, hypomagnesemia, and dehydration. Your clinician may recommend baseline and periodic blood tests (sodium, potassium, creatinine) and may advise a potassium-rich diet or supplementation, particularly if you are on other potassium-lowering therapies. Report symptoms such as muscle cramps, weakness, confusion, severe fatigue, or palpitations.
Metabolic effects: Aquazide may raise uric acid (triggering gout), modestly increase blood sugar, and alter lipids. People with gout, diabetes, metabolic syndrome, or obesity warrant close monitoring. If you have diabetes, check glucose more frequently when starting or adjusting the dose, and discuss any needed changes to your diabetes regimen.
Other considerations: Aquazide can increase sun sensitivity; use sunscreen and protective clothing. It may precipitate acute angle-closure glaucoma or myopia in rare cases—seek urgent care for sudden eye pain or vision changes. Tell your clinician if you have severe liver disease, systemic lupus erythematosus, or a sulfonamide allergy, as these conditions can influence risk and monitoring. During pregnancy, thiazides are generally avoided for routine edema and used only when benefits outweigh risks; low-dose hydrochlorothiazide may be compatible with breastfeeding, but individualized counseling is essential.
Do not use Aquazide if you are unable to urinate (anuria) or if you have a known hypersensitivity to hydrochlorothiazide or other sulfonamide-derived drugs. Severe electrolyte depletion (such as profound hyponatremia or hypokalemia) is a reason to hold therapy until corrected. Always review your full medical history and medication list with a licensed clinician to confirm that Aquazide is appropriate and safe for you.
Common effects include increased urination (especially after the first doses), dizziness or lightheadedness (notably when standing up quickly), headache, photosensitivity, and mild gastrointestinal upset. These often improve as your body adapts. Taking the dose in the morning, rising slowly from sitting or lying positions, and staying hydrated can reduce symptoms.
Metabolic side effects involve changes in electrolytes (low sodium, potassium, or magnesium) and mild increases in uric acid, glucose, or lipids. Clinicians monitor labs and may adjust diet, add a potassium-sparing agent, or modify other medicines to maintain balance. Report new or worsening gout flares, muscle cramps, palpitations, unusual fatigue, or mental status changes promptly.
Serious but uncommon reactions include severe dehydration, symptomatic hypotension, pancreatitis (upper abdominal pain, nausea, vomiting), severe skin reactions (rash, blistering), cholestatic jaundice, blood dyscrasias, and rare acute angle-closure glaucoma. Seek immediate medical attention for chest pain, fainting, vision changes, severe rash, or signs of allergic reaction such as swelling of the face or difficulty breathing.
Electrolyte-related interactions: Low potassium or magnesium from Aquazide can heighten the risk of arrhythmias when combined with digoxin or QT-prolonging agents (for example, certain antiarrhythmics, macrolide antibiotics, or antipsychotics). Corticosteroids and ACTH can worsen hypokalemia. Combining Aquazide with other diuretics or strong antihypertensives can amplify blood pressure lowering, sometimes precipitously, especially after the first doses.
Pharmacologic interactions: NSAIDs (like ibuprofen and naproxen) may blunt the diuretic and antihypertensive effects and can stress the kidneys when combined with diuretics and ACE inhibitors/ARBs—the so‑called “triple whammy.” Lithium clearance is reduced by thiazides, potentially causing lithium toxicity—this combination typically requires avoidance or very close monitoring and dose adjustment. Bile acid sequestrants (cholestyramine, colestipol) can reduce hydrochlorothiazide absorption; spacing doses by several hours helps. Alcohol, barbiturates, and opioids can increase orthostatic hypotension.
Metabolic interactions: Antidiabetic agents (insulin or oral drugs) may require adjustment because thiazides can modestly raise blood glucose. Probenecid or cyclosporine can influence uric acid handling and gout risk. Always share a complete list of prescription drugs, over-the-counter products, herbal supplements, and recreational substances with your clinician and pharmacist before starting Aquazide.
If you miss a dose, take it when you remember unless it is late in the day or close to your next scheduled dose. Because Aquazide increases urination, taking it near bedtime can disrupt sleep; if it is evening, it is usually better to skip the missed dose and resume your regular morning schedule the next day. Do not double up to catch up. If you miss doses frequently, set reminders and speak with your clinician for strategies that fit your routine.
Overdose can cause profound diuresis and dehydration, low blood pressure, dizziness or fainting, electrolyte disturbances (particularly low sodium and potassium), kidney dysfunction, and cardiac rhythm problems. Severe symptoms may include confusion, severe weakness, muscle cramps, vomiting, or loss of consciousness.
If you suspect an overdose, seek emergency medical care or contact Poison Control (in the U.S., 1‑800‑222‑1222) immediately. Do not attempt to self-correct with salt tablets or potassium without guidance. Medical teams will assess vital signs, electrolytes, and kidney function, and provide targeted support such as intravenous fluids and electrolyte replacement.
Store Aquazide tablets at room temperature (generally 20–25°C/68–77°F) in a dry place away from excess heat and humidity. Keep the medication in its original, tightly closed container and out of reach of children and pets. Do not store in the bathroom. Safely discard expired or unused tablets; your pharmacist or local community programs can advise on take‑back options.
In the United States, Aquazide (hydrochlorothiazide) is a prescription medication. By law, reputable pharmacies dispense it only with a valid prescription issued by a licensed clinician after an appropriate evaluation. This protects patients from unsafe self-medication, harmful drug interactions, and counterfeit products. While you cannot legally buy prescription diuretics without a prescription, there are convenient, compliant pathways to care that do not require an in‑person office visit.
HealthSouth Rehabilitation Hospital of Las Vegas supports a legal and structured process by connecting customers with licensed providers for telehealth evaluations when appropriate. If, after review, a clinician determines Aquazide is suitable, they can issue a valid prescription that HealthSouth Rehabilitation Hospital of Las Vegas will fill and ship. This streamlined model preserves safety and regulatory compliance—no prior paper prescription is necessary, but a legitimate prescription is always required. For transparent pricing, pharmacist counseling, and coordinated care, consider HealthSouth Rehabilitation Hospital of Las Vegas’s telehealth-enabled services as a convenient way to access Aquazide responsibly.
Aquazide is a brand of hydrochlorothiazide, a thiazide diuretic used to treat high blood pressure (hypertension) and fluid retention (edema) by helping the kidneys remove excess salt and water.
It blocks sodium-chloride reabsorption in the distal convoluted tubule of the kidney, increasing urine output and reducing blood volume; over time it also lowers peripheral vascular resistance, both of which reduce blood pressure.
Common uses include hypertension, edema from heart failure, liver disease, or kidney disorders, and in select cases to reduce calcium in urine for prevention of certain kidney stones, as directed by a clinician.
Diuretic effects often begin within 2 hours, peak around 4–6 hours, and can last up to 12 hours; full blood pressure–lowering benefit typically develops over several weeks of consistent use.
Usually once daily in the morning, with or without food; take it exactly as prescribed, avoid taking it late in the day to reduce nighttime urination, and do not double doses if you miss one.
Typical daily doses of hydrochlorothiazide range from 12.5 mg to 50 mg depending on the condition and individual response; your clinician will choose the lowest effective dose for you.
Frequent urination, dizziness, fatigue, low blood pressure, muscle cramps, and electrolyte changes such as low potassium or sodium; some people also experience photosensitivity (sun sensitivity).
Severe dehydration, fainting, irregular heartbeat, eye pain or vision changes (rare acute angle-closure glaucoma), severe rash, pancreatitis, or signs of gout (painful, swollen joints); seek urgent care if these occur.
Yes, it can lower potassium. Your clinician may recommend periodic blood tests, a potassium-rich diet, or a supplement/potassium-sparing strategy if needed; never self-supplement without guidance.
Alcohol can enhance dizziness and drop blood pressure further, especially when standing; limit intake and be cautious until you know how the combination affects you.
Notable interactions include increased lithium levels, reduced effect with NSAIDs, enhanced low-potassium risk with corticosteroids or amphotericin, and higher arrhythmia risk with digoxin if potassium is low; review all meds and supplements with your clinician.
Thiazide diuretics are less effective at lower kidney function (e.g., eGFR below about 30 mL/min/1.73 m²) and can worsen electrolyte imbalances; dosing and choice of diuretic should be individualized and closely monitored.
It can modestly raise blood glucose and uric acid levels, potentially unmasking gout or affecting diabetes control; regular monitoring and lifestyle adjustments can help mitigate these effects.
Hydrochlorothiazide has been associated with photosensitivity and, in some observational studies, a higher risk of non-melanoma skin cancers with long-term, high cumulative exposure; use sun protection and discuss risks with your clinician.
Hydrochlorothiazide is a sulfonamide-derived medication. While cross-reactivity is uncommon, inform your healthcare provider about any sulfa allergies so they can assess risks and alternatives.
Periodic checks of blood pressure, electrolytes (especially potassium and sodium), kidney function, uric acid, and sometimes blood glucose and lipids; frequency depends on your health status and dose.
Any weight change is mostly from water loss, not fat; it should not be used for weight loss. Overdiuresis can be harmful.
Take it when you remember unless it’s close to the next dose; skip the missed dose if so. Do not double up.
Thiazide diuretics are generally not first-line in pregnancy and may reduce placental perfusion; use only if clearly needed and directed by an obstetrician. Small amounts can pass into breast milk; discuss risks and alternatives.
It can be used alone or combined with agents like ACE inhibitors, ARBs, beta-blockers, or calcium channel blockers to achieve target blood pressure; combinations are common and individualized.
Chlorthalidone generally has a longer duration and may lower blood pressure more consistently over 24 hours, with stronger outcome data, but it may carry higher risks of low sodium and potassium; Aquazide is widely used and well tolerated for many.
Indapamide tends to have a more neutral effect on glucose and lipids and a long duration of action; Aquazide is effective but may more readily raise glucose and uric acid in susceptible people.
Metolazone retains diuretic effectiveness at lower eGFR and is often paired with loop diuretics for refractory edema; Aquazide is less effective when kidney function is significantly reduced.
No. Chlorthalidone is more potent and longer-acting at a given milligram dose; dose choices are not interchangeable and should be made by a clinician.
Trials suggest indapamide and chlorthalidone have robust cardiovascular outcome data; Aquazide also reduces events via blood pressure lowering, but some guidelines favor thiazide-like agents for outcome evidence.
Chlorthalidone has a higher observed risk of hyponatremia, partly due to its long half-life; careful monitoring is needed with both, especially in older adults and those with low body weight.
Both are thiazide diuretics; bendroflumethiazide (used in some regions) is potent at low doses, while Aquazide (hydrochlorothiazide) is widely available with well-known dosing; choice depends on local practice and patient factors.
Indapamide’s long, smooth action can blunt early-morning surges; Aquazide helps but may not cover the full 24 hours as consistently in some patients.
For resistant edema, especially with reduced kidney function, metolazone is often preferred and combined carefully with loop diuretics; Aquazide may be insufficient alone in that setting.
Evidence from large trials supports chlorthalidone and indapamide for cardiovascular event reduction; Aquazide remains effective for BP control, but some guidelines lean toward thiazide-like agents for outcomes.
Aquazide tends to raise uric acid more than indapamide, increasing gout risk in predisposed individuals; monitoring and lifestyle measures can help.
Thiazides reduce urinary calcium; chlorthalidone and indapamide have supportive data, while recent studies on hydrochlorothiazide show mixed results; selection should be individualized and revisited as evidence evolves.
Aquazide (hydrochlorothiazide) is widely available and inexpensive generically; chlorthalidone and indapamide are also generically available in many regions but may vary in price and supply.
Chlorthalidone and indapamide typically provide more consistent 24-hour coverage than Aquazide; patient tolerance and labs guide the final choice.
Observational data suggest a stronger association with high cumulative hydrochlorothiazide exposure; the signal appears smaller or inconsistent with other thiazide-like agents, but sun protection is advisable for all.